Cardinal Health Inc (CAH)vsHong Kong Pharma Digital Technology Holdings Limited Ordinary shares (HKPD)
CAH
Cardinal Health Inc
$201.77
-1.99%
HEALTHCARE · Cap: $52.43B
HKPD
Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares
$0.49
-2.06%
HEALTHCARE · Cap: $9.28M
Smart Verdict
WallStSmart Research — data-driven comparison
Cardinal Health Inc generates 1532529% more annual revenue ($250.74B vs $16.36M). CAH leads profitability with a 0.6% profit margin vs -4.3%. CAH earns a higher WallStSmart Score of 47/100 (D+).
CAH
Hold47
out of 100
Grade: D+
HKPD
Avoid27
out of 100
Grade: F
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
-29.9%
Fair Value
$170.73
Current Price
$201.77
$31.04 premium
Intrinsic value data unavailable for HKPD.
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Conservative balance sheet, low leverage
Safe zone — low bankruptcy risk
Large-cap with strong market position
Generating 1.7B in free cash flow
Reasonable price relative to book value
Safe zone — low bankruptcy risk
Areas to Watch
Premium valuation, high expectations priced in
ROE of 0.0% — below average capital efficiency
0.6% margin — thin
Operating margin of 1.4%
Smaller company, higher risk/reward
Operating margin of 3.0%
Weak financial health signals
ROE of -17.2% — below average capital efficiency
Comparative Analysis Report
WallStSmart ResearchBull Case : CAH
The strongest argument for CAH centers on Debt/Equity, Altman Z-Score, Market Cap. Revenue growth of 11.0% demonstrates continued momentum. PEG of 1.39 suggests the stock is reasonably priced for its growth.
Bull Case : HKPD
The strongest argument for HKPD centers on Price/Book, Altman Z-Score.
Bear Case : CAH
The primary concerns for CAH are P/E Ratio, Return on Equity, Profit Margin. Thin 0.6% margins leave little buffer for downturns.
Bear Case : HKPD
The primary concerns for HKPD are Market Cap, Operating Margin, Piotroski F-Score.
Key Dynamics to Monitor
CAH profiles as a value stock while HKPD is a turnaround play — different risk/reward profiles.
CAH is growing revenue faster at 11.0% — sustainability is the question.
CAH generates stronger free cash flow (1.7B), providing more financial flexibility.
Monitor MEDICAL DISTRIBUTION industry trends, competitive dynamics, and regulatory changes.
Bottom Line
CAH scores higher overall (47/100 vs 27/100) and 11.0% revenue growth. Both earn "Hold" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Cardinal Health Inc
HEALTHCARE · MEDICAL DISTRIBUTION · USA
Cardinal Health, Inc. is an American multinational health care services company.
Visit Website →Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares
HEALTHCARE · MEDICAL DISTRIBUTION · USA
Hong Kong Pharma Digital Technology Holdings Limited is a pioneering entity in the biotechnology and digital healthcare sectors, focused on enhancing patient outcomes through innovative pharmaceutical services. By harnessing cutting-edge digital technologies and sophisticated data analytics, the company optimizes drug development and boosts operational efficiencies, positioning itself as a key player in the dynamic healthcare landscape. With a commitment to health technology advancement and strategic collaborations, Hong Kong Pharma is well-equipped to meet the evolving needs of both domestic and international markets while propelling innovation within its extensive service offerings.
Compare with Other MEDICAL DISTRIBUTION Stocks
Want to dig deeper into these stocks?